FindTrial
Sign In

Formulation of clinical pathway of joint arthroplasty and establishment of perioperative risk assessment system

Survey study of prognosis of joint arthroplasty

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONC-17013937
Enrollment
Unknown
Registered
2017-12-14
Start date
2013-04-01
Completion date
Unknown
Last updated
2017-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

end-stage knee joint disease

Interventions

clinical pathway group:During hospitalization, patients enter joint arthroplasty clinical pathway.

Sponsors

Beijing Jishuitan Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
22 Years to 78 Years

Inclusion criteria

Inclusion criteria: 1. Patients more than 18 years old; 2. Patients capable of autonomous behivour; 3. Patients having received THA and TKA; 4. Patients volunteer to participate the study and having signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients having received THA or TKA due to tumor; 2. Revision THA or revision TKA.

Design outcomes

Primary

MeasureTime frame
venous thromboembolism including DVT and PE;complications;VAS pain socore;Bleeding volume and transfusion volume;KSS and KOOS score;Harris score and WOMAC score;Length of hospital stay;hospitalization expense;—

Countries

China

Contacts

Public ContactYixin Zhou

Beijing Jishuitan Hospital

pku90901301@126.com+86 15210596573

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026